NCT00314249 - Study of Milnacipran for the Treatment of Fibromyalgia | Biotech Hunter

Enrollment

1,025

Participants

Timeline

Start Date

April 30, 2006

Primary Completion Date

June 30, 2008

Conditions

Fibromyalgia

Interventions

DRUG

Placebo

Placebo, oral administration, twice daily for 12 weeks

DRUG

Milnacipran 100mg

Milnacipran 100mg per day (50mg BID \[twice a day\])

Trial Locations (24)

13210

Forest Investigative Site, Syracuse

13790

Forest Investigative Site, Johnson City

17055

Forest Investigative Site, Mechanicsburg

23454

Forest Investigative Site, Virginia Beach

27408

Forest Investigative Site, Greensboro

29621

Forest Investigative Site, Anderson

29651

Forest Investigative Site, Greer

30328

Forest Investigative Site, Atlanta

33702

Forest Investigative Site, St. Petersburg

33709

Forest Investigative Site, St. Petersburg

34996

Forest Investigative Site, Stuart

35406

Forest Investigative Site, Tuscaloosa

43212

Forest Investigative Site, Columbus

43623

Forest Investigative Site, Toledo

44122

Forest Investigative Site, Cleveland

68134

Forest Investigative Site, Omaha

75080

Forest Investigative Site, Richardson

92083

Forest Investigative Site, Vista

93449

Forest Investigative Site, Pismo Beach

93710

Forest Investigative Site, Fresno

97401

Forest Investigative Site, Eugene

01107

Forest Investigative Site, Springfield

01610

Forest Investigative Site, Worcester

08035

Forest Investigative Site, Haddon Heights